AXIM® Biotech plans to formulate a chewing gum under this invention that contains feverfew extract, cannabidiol (CBD) and/or cannabigerol (CBG) for treatment of symptoms that often accompany migraines.
Read More
ACC has been vetting various partnership and strategic alliance opportunities.
Read More
MariMed has been moving quickly to leverage opportunities in both cannabis and hemp-based CBD markets in the US, Â Europe, and Latin America.
Read More
The campany reported a cash balance increase by $48.2M from year-end to $89.9M at March 31, 2019.
Read More
HEXO intends to acquire all of the issued and outstanding common shares of Newstrike by way of a plan of arrangement under the Business Corporations Act.
Read More
Get stock alerts, news & related alerts straight to your inbox!